Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.86 EUR
Market Cap: 55.5m EUR
Have any thoughts about
Shedir Pharma Srl Unipersonale?
Write Note

Shedir Pharma Srl Unipersonale
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shedir Pharma Srl Unipersonale
PP&E Gross Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Shedir Pharma Srl Unipersonale
MIL:SHE
PP&E Gross
€7.8m
CAGR 3-Years
9%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
PP&E Gross
€183m
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
8%
P
Pierrel SpA
MIL:PRL
PP&E Gross
€37.1m
CAGR 3-Years
40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Friulchem SpA
MIL:FCM
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shedir Pharma Srl Unipersonale
Glance View

Market Cap
55.2m EUR
Industry
Pharmaceuticals

Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

SHE Intrinsic Value
7.59 EUR
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Shedir Pharma Srl Unipersonale's PP&E Gross?
PP&E Gross
7.8m EUR

Based on the financial report for Dec 31, 2023, Shedir Pharma Srl Unipersonale's PP&E Gross amounts to 7.8m EUR.

What is Shedir Pharma Srl Unipersonale's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
-10%

Over the last year, the PP&E Gross growth was 55%. The average annual PP&E Gross growth rates for Shedir Pharma Srl Unipersonale have been 9% over the past three years , -10% over the past five years .

Back to Top